Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Sinocare Inc. (300298.SZ)
CNY15.62
+0.40 (+2.63%)
CN SHZ Healthcare Medical - Devices
Address
No. 265 Guyuan Road 410205
Changsha, HN, CN
Changsha, HN, CN
CEO
Xin Yi Li
Website
sinocare.com
IPO
2012-03-19
ISIN CNE100001CJ0
Description
Sinocare Inc. engages in the development, manufacture, and marketing of rapid diagnosis testing products primarily in the People’s Republic of China. It offers blood glucose and pressure monitors; point of care testing products; digital management tool solutions; non-invasive screening products; and PTS and Trividia products. The company provides its products for the patients with chronic diseases and diabetes, as well as for healthcare professionals. It also exports its products. The company was founded in 2002 and is based in Changsha, the People’s Republic of China.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
CNY15.62
+0.40 (+2.63%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
5M
Beta
-0.09
Float Shares
500.05M
Free Float %
92.0%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | -5.18% | -6.37% | -12.63% | -12.43% | -9.00% | -27.07% | -48.88% | -51.62% | +6.94% | +147.93% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
15.62
DCF (Unlevered)
12.27
-21.4%
DCF (Levered)
60.46
+287.1%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 4 | +1 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
3.54
Safe zone
Piotroski F-Score
8 / 9
Strong
MOAT Score
5 / 10
Developing
Composite Rating
B
Overall Score
3 / 5
Medium
DCF Score
4 / 5
High
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%+4.9% Q1'26: +19.0% (vs Q1'25)
-
EPS growth Medical - Devices: +28.5%-71.2% Q1'26: +38.5% (vs Q1'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%+7.5% ★ Q1'26: +0.6% (vs Q1'25)
-
EBIT margin Medical - Devices: +6.2%+6.3% ★ Q1'26: +12.0% (vs Q1'25)
-
ROIC Medical - Devices: +3.3%+6.4% ★ Q1'26: +17.8% (vs Q1'25)
-
Share dilution Medical - Devices: 0.0%-0.8% ★ Q1'26: -2.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×0.67× ★ Q1'26: 0.38× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 4 Rev. Ana. 2 EPS Ana. |
Dec 2027 5 Rev. Ana. 3 EPS Ana. |
Dec 2028 3 Rev. Ana. 3 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
645.50M
est: 679.00M (-4.9%)
|
795.84M
est: 795.80M (+0.0%)
|
1.03B
est: 1.02B (+1.1%)
|
1.55B
est: 1.63B (-5.0%)
|
1.78B
est: 1.75B (+1.6%)
|
2.02B
est: 2.01B (+0.4%)
|
2.36B
est: 2.30B (+2.5%)
|
3.95B
est: 2.76B (+43.2%)
|
4.06B
est: 4.18B (-3.0%)
|
4.44B
est: 4.36B (+1.8%)
|
4.66B
est: 4.80B (-2.8%)
|
5.08B
5.05B – 5.13B
+5.9% YoY
|
5.60B
5.34B – 6.14B
+10.2% YoY
|
6.23B
6.20B – 6.26B
+11.3% YoY
|
| EBITDA |
127.13M
est: 109.21M (+16.4%)
|
171.43M
est: 128.00M (+33.9%)
|
325.28M
est: 164.33M (+97.9%)
|
369.57M
est: 262.49M (+40.8%)
|
420.06M
est: 281.47M (+49.2%)
|
441.36M
est: 322.80M (+36.7%)
|
353.78M
est: 370.41M (-4.5%)
|
584.42M
est: 443.81M (+31.7%)
|
599.23M
est: 574.93M (+4.2%)
|
621.40M
est: 599.43M (+3.7%)
|
474.32M
est: 658.90M (-28.0%)
|
697.71M
694.34M – 704.40M
+5.9% YoY
|
769.18M
733.51M – 842.93M
+10.2% YoY
|
855.84M
851.31M – 860.38M
+11.3% YoY
|
| EBIT |
112.31M
est: 80.35M (+39.8%)
|
149.70M
est: 94.17M (+59.0%)
|
293.51M
est: 120.90M (+142.8%)
|
318.18M
est: 193.12M (+64.8%)
|
369.77M
est: 207.08M (+78.6%)
|
359.54M
est: 237.49M (+51.4%)
|
256.76M
est: 272.52M (-5.8%)
|
418.65M
est: 326.52M (+28.2%)
|
409.50M
est: 398.41M (+2.8%)
|
434.09M
est: 415.38M (+4.5%)
|
292.65M
est: 456.60M (-35.9%)
|
483.49M
481.15M – 488.13M
+5.9% YoY
|
533.02M
508.30M – 584.13M
+10.2% YoY
|
593.07M
589.93M – 596.22M
+11.3% YoY
|
| Net Income |
143.66M
est: 221.94M (-35.3%)
|
115.20M
est: 126.95M (-9.3%)
|
257.97M
est: 309.30M (-16.6%)
|
310.45M
est: 304.69M (+1.9%)
|
250.68M
est: 315.77M (-20.6%)
|
186.89M
est: 398.86M (-53.1%)
|
107.57M
est: 343.46M (-68.7%)
|
446.51M
est: 424.72M (+5.1%)
|
284.40M
est: 306.51M (-7.2%)
|
326.29M
est: 350.02M (-6.8%)
|
92.65M
est: 268.81M (-65.5%)
|
376.15M
356.41M – 395.89M
+39.9% YoY
|
475.18M
383.81M – 527.10M
+26.3% YoY
|
579.81M
508.54M – 637.01M
+22.0% YoY
|
| SGA |
300.40M
est: 241.45M (+24.4%)
|
340.96M
est: 282.99M (+20.5%)
|
342.30M
est: 363.32M (-5.8%)
|
569.37M
est: 580.34M (-1.9%)
|
625.21M
est: 622.30M (+0.5%)
|
731.07M
est: 713.69M (+2.4%)
|
900.05M
est: 818.95M (+9.9%)
|
1.32B
est: 981.22M (+34.3%)
|
1.39B
est: 1.49B (-6.7%)
|
1.59B
est: 1.56B (+2.2%)
|
1.72B
est: 1.71B (+0.3%)
|
1.81B
1.80B – 1.83B
+5.9% YoY
|
2.00B
1.90B – 2.19B
+10.2% YoY
|
2.22B
2.21B – 2.23B
+11.3% YoY
|
| EPS |
0.38
est: 0.40 (-5.2%)
|
0.24
est: 0.23 (+3.2%)
|
0.53
est: 0.56 (-5.1%)
|
0.56
est: 0.55 (+1.2%)
|
0.45
est: 0.57 (-21.1%)
|
0.34
est: 0.72 (-53.5%)
|
0.19
est: 0.62 (-69.1%)
|
0.80
est: 0.77 (+4.3%)
|
0.51
est: 0.55 (-7.5%)
|
0.59
est: 0.63 (-5.6%)
|
0.17
est: 0.48 (-64.6%)
|
0.67
0.65 – 0.72
+39.9% YoY
|
0.83
0.70 – 0.96
+23.3% YoY
|
1.01
0.92 – 1.16
+21.4% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-28 | B | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-27 | B | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-26 | B | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-25 | B | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-22 | B | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-21 | B | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-20 | B | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-19 | B | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-18 | B | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-15 | B | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-14 | B | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-13 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-12 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-11 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-08 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-07 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-06 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-30 | B | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-29 | B | 3/5 | 5/5 | 2/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-28 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-27 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-24 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-23 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-22 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-21 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-20 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-17 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-16 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-15 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
425.11M
OE per share TTM
0.77
Owner's Yield
5.03%
Maintenance CapEx ratio
43.51%
Maint CapEx / Avg PPE
41.1%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 19 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.01% | 83.9K | 0.65% |
| 2 | State Street SPDR S&P China ETF GXC | 0.01% | 47.6K | 0.59% |
| 3 | State Street SPDR Portfolio Emerging Markets ETF SPEM | 0.00% | 574.5K | 0.07% |
| 4 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 118.4K | 0.39% |
| 5 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.00% | 168.7K | 0.06% |
| 6 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 24.3K | 0.26% |
| 7 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 10.8K | 0.48% |
| 8 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 1.20M | 0.06% |
| 9 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 59.4K | 0.28% |
| 10 | Vanguard Total International Stock ETF VXUS | 0.00% | 1.28M | 0.05% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
58.7K
Shares Outstanding
543.53M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Baishen Ouyang | Chairman of the Supervisory Board & Assistant to the GM | — | male |
| Bo Tan | Accounting Supervisor | — | — |
| Chungeng Chen | Supervisor & Supply Chain Director | — | male |
| Huiyu Xu | Securities Affairs Representative | — | — |
| Jianwen Cai | Deputy General Manager | — | male |
| Jiyun Zheng | Deputy GM & Board Secretary | — | female |
| Shao Bo Huang | Employee Representative Supervisor and Senior Manager of Risk Compliance & Audit Department | — | male |
| Shao Bo Li | Chairman & GM | — | male |
| Shi Min Wang | Deputy General Manager | — | male |
| Zhuzi He | Financial Director | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 300298.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
